Mechanical circulatory support: A clinical reality

Asian Cardiovascular and Thoracic Annals

Volumn 16, Issue 5, 2008, Pages 419-431

  Loisance, Daniel ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT;

ANTICOAGULATION; AORTA BALLOON; ARTIFICIAL HEART; ASSISTED CIRCULATION; CANNULATION; CARDIOGENIC SHOCK; DEVICE INFECTION; DRUG DOSE ESCALATION; EMERGENCY PATIENT; EQUIPMENT DESIGN; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL OXYGENATION; HEART ASSIST DEVICE; HEART CATHETER; HEART FAILURE; HEART FUNCTION; HEART GRAFT; HEART TRANSPLANTATION; HEART VENTRICLE THROMBOSIS; HUMAN; NONHUMAN; POSTOPERATIVE HEMORRHAGE; PUMP; REVIEW; SURGICAL TECHNIQUE; SURVIVAL; THROMBOGENESIS; CHRONIC DISEASE; EMERGENCY TREATMENT; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

CHRONIC DISEASE; EMERGENCY TREATMENT; EQUIPMENT DESIGN; EXTRACORPOREAL CIRCULATION; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; INTRA-AORTIC BALLOON PUMPING; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

EID: 55949105830     PISSN: 02184923     EISSN: None     Source Type: Journal    
DOI: 10.1177/021849230801600518     Document Type: Review

References (37)

1. DeBakey ME. Left ventricular bypass pump for cardiac assistance. Clinical experience. Am J Cardiol 1971;27:3-11.
2. Kantrowitz A, Tjonneland S, Freed PS, Phillips SJ, Butner AN, Sherman JL Jr. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA 1968;203:113-8.
3. Akutsu T, Mirkovitch V, Topaz SR, Kolff WJ. Silastic sac type of artifical heart and its use in calves. Trans Am Soc Artif Intern Organs 1963;9:281-5.
4. Cooley DA, Liotta D, Hallman GL, Bloodwell RD, Leachman RD, Milam JD. Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol 1969;24:723-30.
5. DeVries WC, Anderson JL, Joyce LD, Anderson FL, Hammond EH, Jarvik RK, et al. Clinical use of the total artificial heart. N Engl J Med 1984;310:273-8.
6. Rose EA, Moskowitz AJ, Packer M, Sollano JA, Williams DL, Tierney AR, et al. The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg 1999;67:723-30.
7. Weber TR. Extending the uses of ECMO. Chest 2004;126: 9-10.
8. Mundth ED, Buckley MJ, Daggett WM, McEnamy MT, Leinbach RC, Gold HD, et al. Intra-aortic ballon pump assistance and early surgery in cardiogenic shock. Adv Cardiol 1975;15:159-67.
9. Loisance D, Dubois-Rande JL, Deleuze P, Okude J, Rosenval O, Geschwind H. Prophylactic intraventricular pumping in high-risk coronary angioplasty. Lancet 1990;335:438-40.
10. Jurmann MJ, Siniawski H, Erb M, Drews T, Hetzer R. Initial experience with miniature axial flow ventricular assist devices for postcardiotomy heart failure. Ann Thorac Surg 2004;77:1642-7.
11. Hill JD, Farrar DJ, Hershon JJ, Compton PG, Avery GJ 2nd, Levin BS, et al. Use of a prosthetic ventricle as a bridge to cardiac transplantation for postinfarction cardiogenic shock. N Engl J Med 1986;314:626-8.
12. Farrar DJ, Hill JD, Pennington DG, McBride LR, Holman WL, Kormos RL, et al. Preoperative and postoperative comparison of patients with univentricular and biventricular support with the thoratec ventricular assist device as a bridge to cardiac transplantation. J Thorac Cardiovasc Surg 1997;113:202-9.
13. Farrar DJ, Holman WR, McBride LR, Kormos RL, Icenogle TB, Hendry PJ, et al. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant 2002;21:516-21.
14. Farrar DJ, Buck KE, Coulter JH, Kupa EJ. Portable pneumatic biventricular driver for the Thoratec ventricular assist device. Asaio J 1997;43:M631-34.
15. Slaughter MS. Destination therapy: the future is arriving. Congest Heart Fail 2005;11:155-6.
16. Portner PM, Oyer PE, Jassawalla JS, Miller PJ, Chen H, LaForge DH, et al. An implantable permanent left ventricular assist system for man. Trans Am Soc Artif Intern Organs 1978;24: 99-103.
17. Loisance D, Deleuze PH, Mazzucotelli JP, Abe Y, Le Besnerais P, Dubois-Randé JL. The initial experience with the wearable Baxter Novacor ventricular assist system. J Thorac Cardiovasc Surg 1994;108:176-7.
18. Loisance DY, Deleuze PH, Mazzucotelli JP, Le Besnerais P, Dubois-Randé JL. Clinical implantation of the wearable Baxter Novacor ventricular assist system. Ann Thorac Surg 1994;58: 551-4.
19. Pennington DG, McBride LR, Swartz MT. Implantation technique for the Novacor left ventricular assist system. J Thorac Cardiovasc Surg 1994;108:604-8.
20. Vigano M, Martinelli L, Minzioni G, Rinaldi M, Pagani F. Modified method for Novacor left ventricular assist device implantation. Ann Thorac Surg 1996;61:247-9.
21. Wheeldon DR, LaForge DH, Lee J, Jansen PG, Jassawalla JS, Portner PM. Novacor left ventricular assist system long-term performance: comparison of clinical experience with demonstrated in vitro reliability. Asaio J 2002;48:546-51.
22. Houel R, Moczar M, Ginat M, Loisance D. Pseudointima in inflow and outflow conduits of a left ventricular assist system: possible role in clinical outcome. Asaio J 2001;47:275-81.
23. Lee J, Miller PJ, Chen H, Conley MG, Carpenter JL, Wihera JC, et al. Reliability model from the in vitro durability tests of a left ventricular assist system. Asaio J 1999;45:595-601.
24. Frazier OH, Benedict CR, Radovancevic B, Bick RJ, Capek P, Springer WE, et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg 1996;62:675-82.
25. Spanier TB, Chen JM, Oz MC, Stern DM, Rose EA, Schmidt AM. Time-dependent cellular population of textured-surface left ventricular assist devices contributes to the development of a biphasic systemic procoagulant response. J Thorac Cardiovasc Surg 1999;118:404-13.
26. Oz MC, Argenziano M, Catanese KA, Gardocki MT, Goldstein DJ, Ashton RC, et al. Bridge experience with long-term implantable left ventricular assist devices. Are they an alternative to transplantation? Circulation 1997;95:1844-52.
27. Long JW. Advanced mechanical circulatory support with the HeartMate left ventricular assist device in the year 2000. Ann Thorac Surg 2001;71:S176-84.
28. Goldstein DJ. Worldwide experience with the MicroMed DeBakey Ventricular Assist Device as a bridge to transplantation. Circulation 2003;108(Suppl II):272-7.
29. Griffith BP, Kormos RL, Borovetz HS, Litwak K, Antaki JF, Poirier VL, et al. HeartMate II left ventricular assist system: from concept to first clinical use. Ann Thorac Surg 2001;71:S116-20.
30. Westaby S, Banning AP, Jarvik R, Frazier OH, Pigott DW, Jin XY, et al. First permanent implant of the Jarvik 2000 Heart. Lancet 2000;356:900-03.
31. Potapov EV, Loebe M, Nasseri BA, Sinawski H, Koster A, Kuppe H, et al. Pulsatile flow in patients with a novel nonpulsatile implantable ventricular assist device. Circulation 2000;102(Suppl III): 183-7.
32. Birks EJ, Tansley PD, Hardy J, George RS, Bowles CT, Burke M, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006;355:1873-84.
33. Copeland JG, Smith RG, Arabia FA, Nolan PE, Sethi GK, Tsau PH, et al. Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med 2004;351:859-67.
34. Dowling RD, Ghaly AS, Gray LA Jr. Creation of a diaphragm patch to facilitate placement of the AbioCor implantable replacement heart. Ann Thorac Surg 2004;77:1849-50.
35. Dowling RD, Park SJ, Pagani FD, Tector AJ, Naka Y, Icenogle TB, et al. HeartMate VE LVAS design enhancements and its impact on device reliability. Eur J Cardiothorac Surg 2004;25: 958-63.
36. Adams KF Jr, Zannad F. Clinical definition and epidemiology of advanced heart failure. Am Heart J 1998;135:S204-15.
37. Stevenson LW, Rose EA. Left ventricular assist devices: bridges to transplantation, recovery, and destination for whom? Circulation 2003;108:3059-63.